2Westbrook RH, McFarlane EE, Karajeh M, et al. Treatment of autoimmune hepatitis with mycophenolate mofetil [ J ]. Gut, 2007,56 (suppl2) : A135.
3Kaplan M, Gershwin M. Primary biliary cirrhosis [ J ]. N Engl J Med, 2005,353(9) :1261 - 1273.
4Aldo JML, Albert JC. Current therapy for autoimmune hepatitis [ J]. Gastroenterol Hepato1,2007,14 (4) : 202 - 214.
5Djilali - Saiah I, Renous R, Caillat - Zucman, et al. Linkage disequilibrium between HLA class region and autoimmune hepatitis in pediatric patients [ J ]. J Hepatol,2004,40 ( 11 ) :904 - 909.
6Jiang H, Chess L. Regulation of immune responses by T cells [ J]. N Engl J Med, 2006, 354(11) : 1166 -1176.
8Pietro I, Ana L, Mauro P. Interpreting serological tests in diagnosing autoimmune liver diseases [J]. Semin Liver Dis, 2007,27 ( 2 ) : 161 - 172.
9Gert H, Dirk R, Eugen F, et al. Autoantibodies to asialoglycoprotein receptor ( ASGPR ) measured by a novel ELISA-revival of a disease - activity marker in autoimmune hepatitis [ J ]. Clin Chim Acta,2009,408 (1 -2) :19 -24.
10Muratori L, Granito A, Muratori P, et al. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value[J]. Clin Liver Dis, 2008, 12(2) : 261 -276.
